Related Experiment Video

Updated: Jul 12, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Defective platelet aggregation in myelodysplastic syndromes

Fotios I Girtovitis1, George Ntaios, Athanasios Papadopoulos

  • 1First Propedeutic Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Acta Haematologica
|August 30, 2007
PubMed
Abstract

Insights

Patients with myelodysplastic syndrome (MDS) exhibit impaired platelet aggregation, particularly in response to adrenaline and ADP. This functional defect is linked to worse prognosis in MDS but does not appear to cause bleeding tendencies.

Area of Science:

  • Hematology
  • Oncology
  • Platelet Biology

Background:

  • Hemorrhagic tendency in myelodysplastic syndrome (MDS) is primarily linked to low platelet counts.
  • Platelet function in MDS patients remains underexplored despite its potential clinical significance.

Purpose of the Study:

  • To comprehensively evaluate platelet function in individuals diagnosed with primary MDS.
  • To investigate the impact of various agonists on platelet aggregation in MDS.

Main Methods:

  • Platelet aggregation was assessed using aggregometry in 26 MDS patients and 15 healthy controls.
  • Platelet responses were measured against ristocetin, collagen, adenosine diphosphate (ADP), and adrenaline.

Main Results:

  • A significant majority of MDS patients (80.7%) displayed defective platelet aggregation.
  • The most pronounced defects were observed with adrenaline (45.9%) and ADP (58.7%) stimulation.
  • Refractory anemia with excess blasts in transformation (RAEB-t) subtype showed the most severe platelet dysfunction.

Conclusions:

  • Myelodysplastic syndrome patients frequently exhibit impaired platelet aggregation to multiple stimuli.
  • Platelet aggregation defects in MDS correlate with poorer disease prognosis.
  • Functional platelet defects in MDS do not directly correlate with observed hemorrhagic tendencies.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.